Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent

Genetic or pharmacological ablation of toll-like receptor 2 (TLR2) protects against myocardial ischemia/reperfusion injury (MI/R). However, the endogenous ligand responsible for TLR2 activation has not yet been detected. The objective of this study was to identify HMGB1 as an activator of TLR2 signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mersmann, Jan, Iskandar, Franziska, Latsch, Kathrina, Habeck, Katharina, Sprunck, Vera, Zimmermann, René, Schumann, Ralf R., Zacharowski, Kai, Koch, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859028/
https://www.ncbi.nlm.nih.gov/pubmed/24371373
http://dx.doi.org/10.1155/2013/174168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859028/
https://www.ncbi.nlm.nih.gov/pubmed/24371373
http://dx.doi.org/10.1155/2013/174168

Ejemplares similares